Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Shenqi
900904.SH
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin injection, loquat cough granules, strong loquat dew, loquat cough capsules, jinwu gutong capsules, coral ringworm net, jingwu capsules, quantianma capsules, yindan xintai pills, etc. The company was founded in 1990 and is based in Shanghai, China.
448.02 B
900904.SHMarket value -Rank by Market Cap -/-

Financial Score

25/01/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking177/222
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE2.66%C
    • Profit Margin3.31%C
    • Gross Margin49.36%B
  • Growth ScoreD
    • Revenue YoY-14.92%E
    • Net Profit YoY22.55%B
    • Total Assets YoY-5.36%D
    • Net Assets YoY-2.06%D
  • Cash ScoreC
    • Cash Flow Margin3021.37%A
    • OCF YoY-14.92%E
  • Operating ScoreB
    • Turnover0.6B
  • Debt ScoreA
    • Gearing Ratio21.93%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    U.S. Stock Movement Update: Anteris Tech surges 41.74%, Corvus Pharma drops 10.09% attracting attention

    In the past hour, the overall market in the U.S. stock market has shown a clear divergence, with technology stocks and the biopharmaceutical sector performing particularly well. The strong rise of Anteris Tech Global has attracted a significant inflow of funds, while Corvus Pharma has faced notable selling pressure, indicating a polarization of market sentiment. Short-term enthusiasm has increased among small-cap stocks, especially with active performances from individual stocks like Moolec Science and Senmiao Tech, driving fluctuations in related sectors. Overall, the market pace is relatively fast, with funds frequently switching between different themes, leading to increased volatility. The stock with the largest movement in the past hour, Anteris Tech Global, surged by 41.74%, becoming the market's focal point. The stock quickly rose after the opening, attracting a large amount of short-term funds, with sentiment high, seemingly indicating an optimistic outlook for its future prospects. Strong stocks include: 1. Moolec Science SA: up 9.11%, driven by recent market expectations for its new products, with active short-term funds. 2. Senmiao Tech: up 7.75%, performing well against the backdrop of an overall recovery in technology stocks, attracting considerable investor attention. 3. Rezolve AI: up 7.61%, with the company's recent technological advancements igniting market enthusiasm and noticeable fund inflows

    Tracking Unusual Activity·
    Tracking Unusual Activity·